首页|ST段抬高型急性心肌梗死并发心室颤动患者的临床特点探讨

ST段抬高型急性心肌梗死并发心室颤动患者的临床特点探讨

扫码查看
目的 探讨ST段抬高型急性心肌梗死(心梗)并发心室颤动(室颤)患者的临床特点。方法 选择 276 例ST段抬高型急性心梗患者作为研究对象,患者均行急诊经皮冠状动脉介入术(PCI)治疗,根据患者PCI血管开通前是否发生室颤分为室颤组(50 例)和非室颤组(226 例)。比较两组临床资料,心梗位置与冠脉病变情况,心功能指标与心损指标,预后。结果 室颤组和非室颤组性别和入院时舒张压水平无显著差异(P>0。05)。室颤组患者年龄(69。58±11。02)岁、合并高血压占比 72。00%、合并糖尿病占比 36。00%、入院时心率(89。36±5。28)次/min、Killip分级>Ⅱ级占比 34。00%、合并心房纤颤占比 20。00%和入院时收缩压(135。26±25。13)mm Hg(1 mm Hg=0。133 kPa)显著高于非室颤组的(59。03±13。25)岁、50。44%、22。12%、(78。63±8。23)次/min、19。03%、2。65%、(120。36±14。25)mm Hg(P<0。05)。室颤组心梗位置中前壁占比 74。00%显著高于非室颤组的 40。71%,下壁占比 18。00%显著低于非室颤组的38。05%(P<0。05);室颤组冠脉病变部位中左前降支占比 62。00%显著高于非室颤组的 42。04%(P<0。05);室颤组冠脉病变数目 3 支占比 24。00%显著高于非室颤组的 5。75%(P<0。05)。两组左心室收缩末期内径比较,差异无统计学意义(P>0。05)。室颤组肌酸激酶同工酶(CK-MB)峰值(356。36±25。13)U/L、血浆N端脑钠肽前体(NT-proBNP)(1856。56±425。26)ng/L、血清肌钙蛋白I(cTnI)(15。26±1。25)ng/L显著高于非室颤组的(275。13±31。25)U/L、(958。37±142。01)ng/L、(7。45±1。76)ng/L,左心室舒张末期内径(39。02±4。25)mm、左心房内径(44。07±5。69)mm显著大于非室颤组的(31。25±5。13)、(35。29±7。24)mm,左心室射血分数(46。45±9。68)%、二尖瓣口舒张早期血流速度峰值(E)与舒张晚期血流速度峰值(A)比值(E/A)(0。89±0。17)显著低于非室颤组的(54。02±11。52)%、(1。23±0。24)(P<0。05)。追踪患者预后至 2023 年 5 月,室颤组死亡率 16。00%(8/50)显著高于非室颤组 3。54%(8/226)(χ2=11。640,P<0。05)。结论 ST段抬高型急性心梗并发室颤患者存在一定临床特征,应及时识别,尽早干预,以改善患者预后。
Clinical characteristics of patients with ST-segment elevation acute myocardial infarction complicated with ventricular fibrillation
Objective To explore the clinical characteristics of patients with ST-segment elevation acute myocardial infarction complicated with ventricular fibrillation.Methods 276 cases of ST-segment elevation acute myocardial infarction patients were selected as the study subjects.All patients were treated with emergency percutaneous coronary intervention(PCI),and they were divided into a ventricular fibrillation group(50 cases)and a non-ventricular fibrillation group(226 cases)according to whether they had ventricular fibrillation before PCI vessel patency.The clinical data of the two groups were compared,including myocardial infarction location and coronary artery lesion,cardiac function index and cardiac damage index,prognosis.Results There were no significant differences in gender and diastolic blood pressure on admission between the ventricular fibrillation group and non-ventricular fibrillation group(P>0.05).In the ventricular fibrillation group,the age of patients was(69.58±11.02)years old,72.00%of patients with hypertension,36.00%of patients with diabetes mellitus,34.00%of patients with heart rate of(89.36±5.28)beats/min on admission,34.00%of patients with Killip grade>Ⅱ,20.00%of patients with atrial fibrillation,and the systolic blood pressure was(135.26±25.13)mm Hg(1 mm Hg=0.133 kPa),which were significantly higher than(59.03±13.25)years old,50.44%,22.12%,(78.63±8.23)beats/min,19.03%,2.65%,and(120.36±14.25)mm Hg in the non-ventricular fibrillation group(P<0.05).The percentage of anterior myocardial infarction in the ventricular fibrillation group was 74.00%,which was significantly higher than 40.71%in the non-ventricular fibrillation group;and the percentage of inferior myocardial infarction was 18.00%,which was significantly lower than 38.05%in the non-ventricular fibrillation group(P<0.05).The percentage of coronary lesions in left anterior descending branch in the ventricular fibrillation group was 62.00%,which was significantly higher than 42.04%in the non-ventricular fibrillation group(P<0.05).The number of coronary lesions with 3 branches in the ventricular fibrillation group was 24.00%,which was significantly higher than 5.75%in the non-ventricular fibrillation group(P<0.05).Comparison of left ventricular end-systolic diameter between the two groups showed no statistically significant difference(P>0.05).In ventricular fibrillation group,the peak value of creatine kinase isoenzyme(CK-MB)was(356.36±25.13)U/L,the plasma N-terminal pro-brain natriuretic peptide(NT-proBNP)was(1856.56±425.26)ng/L,and serum troponin I(cTnI)was(15.26±1.25)ng/L,which were significantly higher than(275.13±31.25)U/L,(958.37±142.01)ng/L,and(7.45±1.76)ng/L in the non-ventricular fibrillation group;the left ventricular end-diastolic diameter was(39.02±4.25)mm and the left atrial diameter was(44.07±5.69)mm,which were significantly larger than(31.25±5.13)and(35.29±7.24)mm in the non-ventricular fibrillation group;the left ventricular ejection fraction was(46.45±9.68)%and the ratio of peak mitral flow velocity in early diastole(E)to peak mitral flow velocity in late diastole(A)(E/A)was(0.89±0.17),which were significantly lower than(54.02±11.52)%and(1.23±0.24)in the non-ventricular fibrillation group(P<0.05).The prognosis of patients was followed up until May 2023.The mortality rate in the ventricular fibrillation group was 16.00%(8/50),which was significantly higher than 3.54%(8/226)in the non-ventricular fibrillation group(χ2=11.640,P<0.05).Conclusion Patients with ST-segment elevation acute myocardial infarction complicated with ventricular fibrillation have certain clinical characteristics,which should be identified in time and intervened as early as possible to improve the prognosis of patients.

Acute myocardial infarctionVentricular fibrillationST-segment elevationClinical characteristicsCardiac functionPercutaneous coronary intervention

蔡悦炜、张嫄怡

展开 >

526000 肇庆市第二人民医院急诊科

526000 肇庆医学高等专科学校病理学与病理生理学

急性心肌梗死 心室颤动 ST段抬高型 临床特点 心功能 经皮冠状动脉介入术

肇庆市科技创新指导类项目

2021040307030

2024

中国现代药物应用
中国水利电力医学科学技术学会

中国现代药物应用

影响因子:0.862
ISSN:1673-9523
年,卷(期):2024.18(3)
  • 11